Target intelligence / Profile preview

MicroRNA 4449 (miR-4449)

Target
miR-4449
Molecular classification
MicroRNA, Non-coding RNA, Other
01

Overview

MicroRNA 4449 (miR-4449) is a human microRNA, a small non-coding RNA molecule involved in the post-transcriptional regulation of gene expression. miR-4449 is significantly upregulated in colorectal cancer tissues and cell lines compared with normal counterparts. Functionally, miR-4449 promotes tumor cell proliferation and suppresses apoptosis by activating the STAT3 signaling pathway, in part by repressing SOCS3, a negative regulator of STAT3. Downregulation of miR-4449 in cancer cells reduces STAT3 pathway activity and increases expression of genes associated with apoptosis. miR-4449 is thus considered a potential therapeutic target and a promising biomarker for tumor progression, particularly in colorectal cancer, but might also have roles in other malignancies such as multiple myeloma and lung cancer[1][3][4].

Other names
hsa-miR-4449MIR4449mir-4449
02

Mechanism of action

Antisense inhibition of mature miR-4449 (for oligonucleotide inhibitors); Modulation of gene regulation via direct target binding to 3' UTRs (endogenous function)

03

Biological functions

Gene expression regulationCell proliferationApoptosisSignal transduction (specifically via the STAT3 pathway)
04

Disease associations

Cancer (notably colorectal cancer)Other (evidence also for roles in multiple myeloma and lung cancer, but primary data is for colorectal cancer)
05

Safety considerations

No specific therapeutic safety concerns documented; concerns typical for microRNA-targeted therapies include potential for off-target gene regulation and systemic effects
06

Interacting drugs

hsa-miR-4449 inhibitor (a chemically modified oligonucleotide/inhibitor used in research)
07

Biomarkers

Elevated miR-4449 expression as a putative biomarker for advanced colorectal cancer and disease progression

Beyond the preview

Go deeper on MicroRNA 4449 (miR-4449).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 4449 (miR-4449).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call